NIDDK Central Repository - The so-called "placebo effect" in benign prostatic hyperplasia treatment trials represents partially a conditional regression to the mean induced by censoring.

An official website of the United States government

NIDDK Central Repository

Publication Information

DOI

10.1016/s0090-4295(97)00609-2

PubMed ID

9495705

Public Release Type

Journal

Publication Year

1998

Affiliation

Department of Urology, The University of Texas Southwestern Medical Center at Dallas, 75235-9110, USA.

Authors

Barnboym E, Bernier PA, Brown S, Gregory A, Montoya JD, Roehrborn CG, Sech SM

Studies

ICDB

Citation

Sech SM, Montoya JD, Bernier PA, Barnboym E, Brown S, Gregory A, Roehrborn CG. The so-called "placebo effect" in benign prostatic hyperplasia treatment trials represents partially a conditional regression to the mean induced by censoring. Urology 1998 Feb;51(2):242-50.

Abstract

To study the variability of assessment instruments (symptom questionnaires and flow rate recordings) in healthy volunteers during repeat administration in short intervals. To study the effect of inclusion criteria-based censoring of patients during screening for benign prostatic hyperplasia (BPH) treatment trials on the outcome of subsequent tests.